Eledon Pharmaceuticals (ELDN) Current Assets (2016 - 2017)
Historic Current Assets for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to $21.0 million.
- Eledon Pharmaceuticals' Current Assets fell 4210.66% to $21.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $21.0 million, marking a year-over-year decrease of 4210.66%. This contributed to the annual value of $1.2 million for FY2016, which is 9828.79% down from last year.
- Per Eledon Pharmaceuticals' latest filing, its Current Assets stood at $21.0 million for Q3 2017, which was down 4210.66% from $24.8 million recorded in Q2 2017.
- In the past 5 years, Eledon Pharmaceuticals' Current Assets registered a high of $107.5 million during Q4 2014, and its lowest value of $1.2 million during Q4 2016.
- For the 5-year period, Eledon Pharmaceuticals' Current Assets averaged around $56.1 million, with its median value being $51.6 million (2016).
- Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 23411.34% in 2014, then plummeted by 9828.79% in 2016.
- Over the past 5 years, Eledon Pharmaceuticals' Current Assets (Quarter) stood at $32.2 million in 2013, then surged by 234.11% to $107.5 million in 2014, then tumbled by 37.52% to $67.2 million in 2015, then tumbled by 98.29% to $1.2 million in 2016, then skyrocketed by 1729.13% to $21.0 million in 2017.
- Its last three reported values are $21.0 million in Q3 2017, $24.8 million for Q2 2017, and $25.6 million during Q1 2017.